-Protopanaxatriol-chemical-structure.gif)
20(S)-Protopanaxatriol enhanced adipogenesis by increasing the expression of PPARgamma target genes such as aP2, LPL and PEPCK. Furthermore, 20(S)-Protopanaxatriol significantly increased expression of glucose transporter 4 (GLUT4).20(S)-Protopanaxatriol can be developed as a PPARgamma agonist for the improvement of insulin resistance associated with diabetes.PPD and PPT may exhibit the anxiolytic effect via γ-aminobutyrateA (GABAA) receptor(s) and serotonergic receptor(s), respectively.
| Molecular Weight | 476.73 |
| Formula | C30H52O4 |
| CAS Number | 34080-08-5 |
| Form | Solid |
| Solubility (25°C) | DMSO 47mg/ml |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Species | Mouse | Rat | Rabbit | Guinea pig | Hamster | Dog |
| Weight (kg) | 0.02 | 0.15 | 1.8 | 0.4 | 0.08 | 10 |
| Body Surface Area (m2) | 0.007 | 0.025 | 0.15 | 0.05 | 0.02 | 0.5 |
| Km factor | 3 | 6 | 12 | 8 | 5 | 20 |
| Animal A (mg/kg) = Animal B (mg/kg) multiplied by | Animal B Km |
| Animal A Km |
For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.
| Related GCR Products |
|---|
| ORIC-101
ORIC-101 is a potent and selective glucocorticoid receptor antagonist with an EC50 value of 5.6 nM and anticancer activity. |
| Mometasone Furoate Monohydrate
Mometasone Furoate Monohydrate is a glucocorticoid receptor agonist with anti-inflammatory and anti-allergic activity. |
| RU 26988
RU 26988 is a highly specific glucocorticoid receptor agonist. |
| HP210
HP210 is a selective glucocorticoid receptor modulator (SGRM). |
| Glucocorticoid receptor modulator 2
Glucocorticoid receptor modulator 2 is a glucocorticoid receptor modulator, with an IC50 value less than 100 nM. |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
